Three dozen institutional investors are urging the boards at several of the world’s largest pharmaceutical companies to establish concrete metrics for linking executive compensation with policies that widen access to… […]
Scientific meetings about Alzheimer’s disease can be funereal affairs. But this year’s Clinical Trials in Alzheimer’s Disease meeting felt markedly different. […]
Ginkgo, a company that said its engineered cells could help make almost anything, is trying to drum up business. […]
Copyright © 2022 Biotech Networks, LLC
